188 related articles for article (PubMed ID: 15854132)
1. Apoptosis in CD30-positive lymphoproliferative disorders of the skin.
Greisser J; Doebbeling U; Roos M; Mueller B; Schmid M; Burg G; Kadin ME; Kempf W
Exp Dermatol; 2005 May; 14(5):380-5. PubMed ID: 15854132
[TBL] [Abstract][Full Text] [Related]
2. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
3. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
Kikuchi A; Nishikawa T
Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
Benner MF; Jansen PM; Meijer CJ; Willemze R
Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
[TBL] [Abstract][Full Text] [Related]
6. Pathobiology of CD30+ cutaneous T-cell lymphomas.
Kadin ME
J Cutan Pathol; 2006 Feb; 33 Suppl 1():10-7. PubMed ID: 16412208
[TBL] [Abstract][Full Text] [Related]
7. Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics.
Kaudewitz P; Stein H; Dallenbach F; Eckert F; Bieber K; Burg G; Braun-Falco O
Am J Pathol; 1989 Aug; 135(2):359-67. PubMed ID: 2551170
[TBL] [Abstract][Full Text] [Related]
8. FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations.
Gjerdrum LM; Woetmann A; Odum N; Hother C; Henrik-Nielsen R; Gniadecki R; Ralfkiaer E
Eur J Haematol; 2008 Jun; 80(6):483-9. PubMed ID: 18331599
[TBL] [Abstract][Full Text] [Related]
9. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders.
Drakos E; Leventaki V; Schlette EJ; Jones D; Lin P; Medeiros LJ; Rassidakis GZ
Am J Surg Pathol; 2007 Mar; 31(3):447-53. PubMed ID: 17325487
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily.
Paulli M; Berti E; Boveri E; Kindl S; Bonoldi E; Gambini C; Rosso R; Borroni G; Straccapansa V; Magrini U; DeCoteau JE; Krammer PH; Möller P; Kadin ME
Hum Pathol; 1998 Nov; 29(11):1223-30. PubMed ID: 9824099
[TBL] [Abstract][Full Text] [Related]
11. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators.
Kempf W
J Cutan Pathol; 2006 Feb; 33 Suppl 1():58-70. PubMed ID: 16412214
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases.
Plaza JA; Feldman AL; Magro C
J Cutan Pathol; 2013 Feb; 40(2):236-47. PubMed ID: 23189966
[TBL] [Abstract][Full Text] [Related]
13. Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.
De Souza A; Tinguely M; Pfaltz M; Burghart DR; Kempf W
J Cutan Pathol; 2014 Dec; 41(12):901-6. PubMed ID: 25353265
[TBL] [Abstract][Full Text] [Related]
14. Borderline CD30+ cutaneous lymphoproliferative disorder: report of a case with expression of cytotoxic markers and response to clarithromycin.
Ponte P; Serrão V; Viana I; Vale E; João A; Cerroni L
J Cutan Pathol; 2011 Mar; 38(3):301-5. PubMed ID: 19922478
[TBL] [Abstract][Full Text] [Related]
15. The expression of MUM1 in cutaneous T-cell lymphoproliferative disorders.
Wasco MJ; Fullen D; Su L; Ma L
Hum Pathol; 2008 Apr; 39(4):557-63. PubMed ID: 18234282
[TBL] [Abstract][Full Text] [Related]
16. Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas.
Kempf W; Kazakov DV; Schärer L; Rütten A; Mentzel T; Paredes BE; Palmedo G; Panizzon RG; Kutzner H
Am J Surg Pathol; 2013 Jan; 37(1):1-13. PubMed ID: 23026936
[TBL] [Abstract][Full Text] [Related]
17. Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders.
Greisser J; Palmedo G; Sander C; Kutzner H; Kazakov DV; Roos M; Burg G; Kempf W
J Cutan Pathol; 2006 Nov; 33(11):711-5. PubMed ID: 17083688
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
Paulli M; Berti E
Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
[TBL] [Abstract][Full Text] [Related]
19. Large CD30-positive cells in benign, atypical lymphoid infiltrates of the skin.
Werner B; Massone C; Kerl H; Cerroni L
J Cutan Pathol; 2008 Dec; 35(12):1100-7. PubMed ID: 18616762
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and proliferation in subcutaneous panniculitis-like T-cell lymphoma.
Sen F; Rassidakis GZ; Jones D; Medeiros LJ
Mod Pathol; 2002 Jun; 15(6):625-31. PubMed ID: 12065776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]